{"id":"W2588916936","doi":"10.1182/blood.v128.22.792.792","title":"Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Medicine; Internal medicine; Imatinib; Clinical endpoint; Imatinib mesylate; Interim analysis; Myeloid leukemia; Gastroenterology; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001892302,0.0006166217,0.001227391,0.0007888737,0.0001092377,0.0000431194,0.0004042483,0.000217081,0.0001398849],"category_scores_gemma":[0.0004718918,0.0004197049,0.0002531878,0.001258035,0.00002556682,0.0002469532,0.0001755918,0.000178182,0.00005552002],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01769508,"about_ca_system_score_gemma":0.001909198,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0120508,"about_ca_topic_score_gemma":0.01188095,"domain_scores_codex":[0.996341,0.00009601359,0.0008080365,0.001310674,0.0005193254,0.0009249653],"domain_scores_gemma":[0.9969414,0.0005770409,0.0002590204,0.001594848,0.00007719714,0.0005505163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003435212,0.001878539,0.8338159,0.0000430027,0.001594405,0.0001244777,0.0008897659,0.0001525183,0.07774485,0.000005803269,0.00006821613,0.08024736],"study_design_scores_gemma":[0.2306355,0.008409856,0.7031063,0.00283978,0.004340271,0.000005526069,0.0001704779,0.0008938563,0.04774235,0.00008758657,0.0007955176,0.0009729528],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942868,0.0003407128,0.001424251,0.0004359421,0.00008419799,0.002683072,0.0005465722,0.0001201537,0.00007825511],"genre_scores_gemma":[0.9897877,0.00004422085,0.00809131,0.00008905686,0.0003511773,0.0006529444,0.0006996852,0.0001180396,0.0001658627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2272003,"threshold_uncertainty_score":0.9998255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.013697153198881,"score_gpt":0.2777121560676303,"score_spread":0.2640150028687493,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}